| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 1e-05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |